{"id":"doxycycline-tablets","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Nausea"},{"rate":"5-10","effect":"Vomiting"},{"rate":"10-15","effect":"Diarrhea"},{"rate":"3-10","effect":"Photosensitivity"},{"rate":"1-5","effect":"Esophageal irritation"},{"rate":"1-5","effect":"Vaginal candidiasis"},{"rate":"1-3","effect":"Headache"}]},"_chembl":null,"_dailymed":{"setId":"ddd9a47e-7d7c-4d0c-aaa6-32702570f696","title":"BENZODOX 30 KIT (DOXYCYCLINE TABLETS AND ADVANCED ACNE WASH) KIT [ELORAC, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Doxycycline is a tetracycline antibiotic that binds reversibly to the bacterial 30S ribosomal subunit, blocking the attachment of aminoacyl-tRNA to the mRNA-ribosome complex. This inhibits protein synthesis and is bacteriostatic, stopping bacterial growth and allowing the immune system to clear the infection. It is effective against a broad spectrum of gram-positive and gram-negative bacteria, as well as some atypical organisms.","oneSentence":"Doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing peptide bond formation and bacterial growth.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:45:01.728Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections including respiratory tract infections, urinary tract infections, and skin infections"},{"name":"Malaria prophylaxis and treatment"},{"name":"Acne vulgaris"},{"name":"Lyme disease"},{"name":"Chlamydial infections"}]},"trialDetails":[{"nctId":"NCT07485842","phase":"PHASE4","title":"FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University","startDate":"2026-04","conditions":"Chronic Endometritis","enrollment":300},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT06120140","phase":"PHASE2","title":"Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-02-16","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":300},{"nctId":"NCT05296837","phase":"PHASE4","title":"Ocular Rosacea Biome Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-06-22","conditions":"Ocular Rosacea, Antimicrobial Resistance","enrollment":50},{"nctId":"NCT07357337","phase":"PHASE4","title":"Efficacy of Oral Metformin vs Oral Doxycycline in Treating Acne Vulgaris","status":"COMPLETED","sponsor":"Ghurki Trust and Teaching Hospital","startDate":"2025-02-15","conditions":"Acne Vulgaris on the Face, Acne Vulgaris","enrollment":68},{"nctId":"NCT04686799","phase":"PHASE1","title":"Doxycycline for Elbow Tendinopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2020-12-03","conditions":"Lateral Epicondylitis, Lateral Epicondylitis, Left Elbow, Lateral Epicondylitis, Right Elbow","enrollment":25},{"nctId":"NCT07215325","phase":"PHASE4","title":"Got Doxy- 'Flipping the Script' on STI PEP","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-10-22","conditions":"Sexually Transmitted Infections (STI)","enrollment":200},{"nctId":"NCT03637400","phase":"PHASE2","title":"Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2018-11-26","conditions":"Methicillin-resistant Staphylococcus Aureus, Skin Infection","enrollment":269},{"nctId":"NCT07230028","phase":"PHASE4","title":"Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study.","status":"NOT_YET_RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2026-03-01","conditions":"Lyme Borreliosis, Nervous System","enrollment":50},{"nctId":"NCT04067011","phase":"PHASE2","title":"Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study","status":"COMPLETED","sponsor":"Emergent BioSolutions","startDate":"2019-08-12","conditions":"Anthrax","enrollment":210},{"nctId":"NCT05448937","phase":"PHASE2, PHASE3","title":"Lesion Sterilization And Tissue Repair Versus Zinc Oxide And Eugenol For Treatment of Necrotic Primary Molars","status":"COMPLETED","sponsor":"Cairo University","startDate":"2022-10-01","conditions":"Necrotic Primary Molars","enrollment":60},{"nctId":"NCT04297592","phase":"PHASE4","title":"Antibiotic Prophylaxis in High-Risk Arthroplasty Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2020-06-11","conditions":"Infections Joint Prosthetic, Overweight or Obesity, MSSA Colonization","enrollment":4618},{"nctId":"NCT03337932","phase":"NA","title":"Duration of Doxycycline Treatment in MEM Patients","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2018-05-01","conditions":"Erythema Chronicum Migrans","enrollment":200},{"nctId":"NCT06693362","phase":"PHASE1","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-01-20","conditions":"Severe Viral Pneumonia(Not Include COVID-19)","enrollment":60},{"nctId":"NCT05972772","phase":"PHASE2, PHASE3","title":"Rickettsia Clearance Study","status":"RECRUITING","sponsor":"Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit","startDate":"2024-11-01","conditions":"Infectious Disease, Therapeutics","enrollment":72},{"nctId":"NCT04846335","phase":"PHASE2","title":"Familiar Fatal Insomnia: Preventive Treatment With Doxycycline in Subject With Disease Risk","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2011-04-28","conditions":"Familial Fatal Insomnia","enrollment":29},{"nctId":"NCT05111002","phase":"PHASE1, PHASE2","title":"Lefamulin for M. Genitalium Treatment Failures","status":"TERMINATED","sponsor":"University of Washington","startDate":"2022-04-22","conditions":"Mycoplasma Genitalium Infection","enrollment":12},{"nctId":"NCT05157412","phase":"PHASE3","title":"Role of Doxycycline in Chronic Rhinosinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Assiut University","startDate":"2021-07-01","conditions":"Nasal Polyps, Chronic Rhinosinusitis With Nasal Polyps","enrollment":60},{"nctId":"NCT02844634","phase":"PHASE4","title":"Tenofovir/Emtricitabine With Doxycycline for Combination HIV and Syphilis Pre-exposure Prophylaxis in HIV-negative MSM","status":"COMPLETED","sponsor":"British Columbia Centre for Disease Control","startDate":"2018-05-15","conditions":"HIV, Syphilis","enrollment":52},{"nctId":"NCT04597424","phase":"PHASE3","title":"Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2021-01-19","conditions":"Unsafe Sex, Risk-Taking","enrollment":556},{"nctId":"NCT00647959","phase":"PHASE1","title":"Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2006-03","conditions":"Healthy","enrollment":36},{"nctId":"NCT00648180","phase":"PHASE1","title":"Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-07","conditions":"Healthy","enrollment":36},{"nctId":"NCT00649571","phase":"PHASE1","title":"Fasting Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-07","conditions":"Healthy","enrollment":35},{"nctId":"NCT06252194","phase":"PHASE2","title":"Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients.","status":"UNKNOWN","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2023-03-05","conditions":"Acne Vulgaris","enrollment":120},{"nctId":"NCT06172686","phase":"PHASE1","title":"In-vivo Transmission Model in Semi-immune Adults","status":"UNKNOWN","sponsor":"Ifakara Health Institute","startDate":"2024-01-09","conditions":"Controlled Human Malaria Infection, Induced Blood Stage Malaria Infection, Malaria Transmission","enrollment":24},{"nctId":"NCT05112211","phase":"NA","title":"Multi-model Image of Doxycycline in TAO","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2022-01-01","conditions":"Thyroid Associated Ophthalmopathy","enrollment":20},{"nctId":"NCT06101420","phase":"PHASE3","title":"Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-01-01","conditions":"Helicobacter Pylori Eradication","enrollment":232},{"nctId":"NCT06090565","phase":"PHASE4","title":"Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea","status":"COMPLETED","sponsor":"Bulovka Hospital","startDate":"2021-04-01","conditions":"Gonorrhea","enrollment":161},{"nctId":"NCT00066027","phase":"PHASE3","title":"Effects of Low-Dose Doxycycline on Oral Bone Loss","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2002-06-01","conditions":"Periodontitis","enrollment":128},{"nctId":"NCT05897034","phase":"PHASE2, PHASE3","title":"Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2023-06-20","conditions":"Sexually Transmitted Diseases","enrollment":100},{"nctId":"NCT04723069","phase":"PHASE2","title":"Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases","status":"COMPLETED","sponsor":"University of Karachi","startDate":"2021-09-21","conditions":"Pelvic Inflammatory Disease","enrollment":198},{"nctId":"NCT02899000","phase":"PHASE4","title":"A Treatment for Severe Inflammatory Acne Subjects","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-07-29","conditions":"Acne Vulgaris","enrollment":186},{"nctId":"NCT05445362","phase":"NA","title":"Efficacy of Diode Laser in Maturogenesis of Immature Teeth With Necrotic Pulps","status":"COMPLETED","sponsor":"Reham Hassan","startDate":"2019-02-01","conditions":"Effects of the Elements","enrollment":39},{"nctId":"NCT03173053","phase":"NA","title":"S. Aureus Decolonization in HPN Patients.","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2018-02-08","conditions":"Staphylococcus Aureus, Motility Disorder","enrollment":63},{"nctId":"NCT04451330","phase":"PHASE4","title":"A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2020-07-29","conditions":"Acne Vulgaris","enrollment":202},{"nctId":"NCT04371952","phase":"PHASE3","title":"DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19)","status":"WITHDRAWN","sponsor":"Nantes University Hospital","startDate":"2021-02-01","conditions":"COVID19","enrollment":""},{"nctId":"NCT05040334","phase":"PHASE4","title":"Role of Prophylactic Antibiotics in Preventing Pelvic Infection After Surgical Evacuation","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2021-01-01","conditions":"Antibiotics Causing Adverse Effects in Therapeutic Use","enrollment":138},{"nctId":"NCT03342456","phase":"PHASE4","title":"The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers","status":"COMPLETED","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2017-12-13","conditions":"Duodenal Ulcer Due to Helicobacter Pylori","enrollment":184},{"nctId":"NCT02203682","phase":"PHASE2","title":"Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2014-07","conditions":"Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy","enrollment":100},{"nctId":"NCT03618108","phase":"PHASE2","title":"Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease","status":"TERMINATED","sponsor":"Cadrock Pty. Ltd.","startDate":"2018-04-04","conditions":"Coronary Heart Disease, Chlamydophila Pneumoniae Infections","enrollment":20},{"nctId":"NCT02929121","phase":"PHASE3","title":"A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India","status":"COMPLETED","sponsor":"The Task Force for Global Health","startDate":"2019-01-15","conditions":"Lymphedema, Lymphatic Filariasis, Filariasis","enrollment":235},{"nctId":"NCT02927496","phase":"PHASE3","title":"A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali","status":"COMPLETED","sponsor":"The Task Force for Global Health","startDate":"2018-06-19","conditions":"Lymphedema, Lymphatic Filariasis, Filariasis","enrollment":220},{"nctId":"NCT02564471","phase":"PHASE4","title":"Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.","status":"COMPLETED","sponsor":"State University of New York - Upstate Medical University","startDate":"2016-11-11","conditions":"Rabies","enrollment":103},{"nctId":"NCT02341209","phase":"PHASE2","title":"Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma","status":"TERMINATED","sponsor":"Rochester General Hospital","startDate":"2018-02-06","conditions":"Cutaneous T-cell Lymphoma, Mycosis Fungoides, Sezary Syndrome","enrollment":1},{"nctId":"NCT04433078","phase":"PHASE2","title":"RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM","status":"WITHDRAWN","sponsor":"Temple University","startDate":"2020-06-22","conditions":"Cytokine Storm, SARS-CoV-2","enrollment":""},{"nctId":"NCT04729140","phase":"PHASE4","title":"An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization","status":"UNKNOWN","sponsor":"Max Health, Subsero Health","startDate":"2020-12-28","conditions":"Covid19","enrollment":150},{"nctId":"NCT04150250","phase":"PHASE2","title":"Cholera Anti-Secretory Treatment Trial","status":"COMPLETED","sponsor":"PATH","startDate":"2019-11-04","conditions":"Cholera","enrollment":47},{"nctId":"NCT02929134","phase":"PHASE3","title":"A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka","status":"COMPLETED","sponsor":"The Task Force for Global Health","startDate":"2018-02-16","conditions":"Lymphedema, Lymphatic Filariasis, Filariasis","enrollment":219},{"nctId":"NCT01320033","phase":"PHASE2","title":"Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-03-29","conditions":"Acne Vulgaris","enrollment":662},{"nctId":"NCT00688064","phase":"PHASE3","title":"Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-08","conditions":"Severe Acne Vulgaris","enrollment":459},{"nctId":"NCT04239755","phase":"PHASE4","title":"Doxycycline in Acute Traumatic Brain Injury","status":"COMPLETED","sponsor":"Damanhour University","startDate":"2020-02-01","conditions":"Traumatic Brain Injury","enrollment":50},{"nctId":"NCT04407130","phase":"PHASE2","title":"Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2020-06-16","conditions":"COVID-19 Patients","enrollment":72},{"nctId":"NCT04715295","phase":"PHASE4","title":"Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19","status":"UNKNOWN","sponsor":"Yaounde Central Hospital","startDate":"2020-10-05","conditions":"COVID-19","enrollment":200},{"nctId":"NCT04636125","phase":"PHASE3","title":"Prospective Evaluation of Oral Antibiotics for Treatment of Shoulder PJI","status":"UNKNOWN","sponsor":"Rothman Institute Orthopaedics","startDate":"2019-09-24","conditions":"Periprosthetic Infection, Oral Antibiotics, Revision Total Shoulder Arthroplasty","enrollment":100},{"nctId":"NCT03194204","phase":"NA","title":"Re-evaluation of Some Old Rheumatoid Arthritis Therapy: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-10-01","conditions":"Rheumatoid Arthritis","enrollment":160},{"nctId":"NCT02456662","phase":"NA","title":"Scheduled Prophylactic Antiemetics for Reduction of Emesis With Doxycycline (SPARED) Trial","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2015-10-07","conditions":"Drug-induced Nausea and Vomiting","enrollment":319},{"nctId":"NCT03448731","phase":"PHASE2","title":"Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA)","status":"COMPLETED","sponsor":"Fundacion CRIS de Investigación para Vencer el Cáncer","startDate":"2018-05-10","conditions":"Skin Toxicity","enrollment":34},{"nctId":"NCT03153267","phase":"NA","title":"Duration of Doxycycline Treatment in EM Patients","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2017-06-01","conditions":"Erythema Chronicum Migrans","enrollment":300},{"nctId":"NCT01635530","phase":"PHASE4","title":"Study of Lyme Neuroborreliosis","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2012-08","conditions":"Lyme Neuroborreliosis","enrollment":210},{"nctId":"NCT00322465","phase":"PHASE2","title":"NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-11","conditions":"Urethritis","enrollment":305},{"nctId":"NCT01594827","phase":"PHASE2","title":"Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-10","conditions":"Cystic Fibrosis","enrollment":29},{"nctId":"NCT00358462","phase":"PHASE3","title":"Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)","status":"COMPLETED","sponsor":"University of Washington","startDate":"2007-01","conditions":"Urethritis","enrollment":606},{"nctId":"NCT03532464","phase":"PHASE4","title":"Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection","status":"UNKNOWN","sponsor":"University Hospital, Bordeaux","startDate":"2018-07-01","conditions":"Chlamydia Trachomatis Infection, Vaginal Infection, Anal Infection","enrollment":460},{"nctId":"NCT03533231","phase":"PHASE4","title":"Efficiency of Triple Antibiotic Paste, Ciprofloxacin/Propolis, Ciprofloxacin/Metronidazole, Propolis/Metronidazole Combinations on Revascularization Process of Immature Necrotic Maxillary Incisors of Patients 8-18 Years Old.","status":"COMPLETED","sponsor":"Tariq Yehia","startDate":"2015-01-16","conditions":"Dental Pulp Necrosis, Periapical Abscess, Root Canal Infection","enrollment":40},{"nctId":"NCT00246740","phase":"PHASE2","title":"Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2005-10","conditions":"Coronary Artery Bypass Grafting, Cardiopulmonary Bypass, Reperfusion Injury","enrollment":56},{"nctId":"NCT01380496","phase":"PHASE1","title":"Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions","status":"COMPLETED","sponsor":"Par Pharmaceutical, Inc.","startDate":"1999-11","conditions":"To Determine Bioequivalence Under Fed Conditions","enrollment":24},{"nctId":"NCT01323101","phase":"PHASE4","title":"Doxycycline Effects on Inflammation in Cystic Fibrosis","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2008-04","conditions":"Cystic Fibrosis","enrollment":21},{"nctId":"NCT01112059","phase":"NA","title":"Trial of Doxycycline to Reduce Sputum MMP-9 Activity in Adult Cystic Fibrosis (CF) Patients","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2008-11","conditions":"Cystic Fibrosis","enrollment":40},{"nctId":"NCT00980148","phase":"PHASE3","title":"Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2009-12","conditions":"Chlamydial Infection","enrollment":567},{"nctId":"NCT00803842","phase":"NA","title":"Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash","status":"WITHDRAWN","sponsor":"Northwestern University","startDate":"2008-10","conditions":"Non Small Cell Lung Cancer","enrollment":""},{"nctId":"NCT02174757","phase":"PHASE3","title":"Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis","status":"COMPLETED","sponsor":"CD Pharma India Pvt. Ltd.","startDate":"2014-08","conditions":"Chronic Periodontitis","enrollment":30},{"nctId":"NCT01661985","phase":"PHASE4","title":"Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced","status":"UNKNOWN","sponsor":"Ostergotland County Council, Sweden","startDate":"2010-02","conditions":"Urethritis, Cervicitis, Genital Mycoplasma Infection","enrollment":160},{"nctId":"NCT01368341","phase":"PHASE4","title":"Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice","status":"COMPLETED","sponsor":"Morten Lindbaek","startDate":"2011-06","conditions":"Erythema Migrans, Erythema Chronicum Migrans, Borreliosis","enrollment":225},{"nctId":"NCT00480532","phase":"NA","title":"A Study of Continuous Oral Contraceptives and Doxycycline","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2007-05","conditions":"Contraceptives, Oral","enrollment":131},{"nctId":"NCT01935622","phase":"PHASE2","title":"Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy","status":"TERMINATED","sponsor":"Virginia Commonwealth University","startDate":"2012-07","conditions":"Non-ischemic Cardiomyopathy, Systolic Heart Failure (NYHA II-III)","enrollment":10},{"nctId":"NCT01727973","phase":"PHASE1, PHASE2","title":"Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2012-10","conditions":"Graves Ophthalmopathy, Graves Disease, Eye Diseases","enrollment":14},{"nctId":"NCT02005653","phase":"PHASE4","title":"Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti Infection","status":"COMPLETED","sponsor":"Indian Council of Medical Research","startDate":"2009-02","conditions":"Filarial; Infestation","enrollment":146},{"nctId":"NCT01886560","phase":"PHASE2, PHASE3","title":"Low Dose Doxycycline in the Treatment of Corneal Burn","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2013-09","conditions":"Eye Burns","enrollment":40},{"nctId":"NCT00031499","phase":"PHASE3","title":"Azithromycin/Bicillin Syphilis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2000-06","conditions":"Syphilis","enrollment":593},{"nctId":"NCT01730352","phase":"PHASE2, PHASE3","title":"Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2008-10","conditions":"Immune Thrombocytopenic Purpura, Helicobacter Pylori Infection","enrollment":100},{"nctId":"NCT00635609","phase":"PHASE4","title":"Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate","status":"COMPLETED","sponsor":"Warner Chilcott","startDate":"2008-03","conditions":"Acne Vulgaris","enrollment":93},{"nctId":"NCT01113931","phase":"PHASE3","title":"Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin","status":"COMPLETED","sponsor":"Warner Chilcott","startDate":"2010-04","conditions":"Urogential Chlamydia Trachomatis Infection","enrollment":495},{"nctId":"NCT01380483","phase":"PHASE1","title":"Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Par Pharmaceutical, Inc.","startDate":"2000-01","conditions":"To Determine Bioequivalence Under Fasting Conditions","enrollment":40},{"nctId":"NCT00939562","phase":"PHASE4","title":"Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-11","conditions":"Bacterial Infection","enrollment":24},{"nctId":"NCT00857038","phase":"PHASE4","title":"Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD)","status":"UNKNOWN","sponsor":"Medical Center Alkmaar","startDate":"2009-04","conditions":"Chronic Obstructive Pulmonary Disease, Inflammation, Pulmonary Emphysema","enrollment":30},{"nctId":"NCT00775918","phase":"NA","title":"Bioequivaelnce Study of Doxycycline Monohydrate 100mg Tablets Under Fed Conditions","status":"COMPLETED","sponsor":"Ranbaxy Laboratories Limited","startDate":"2005-06","conditions":"Healthy","enrollment":32},{"nctId":"NCT00775177","phase":"NA","title":"Bioequivalence Study of Doxycycline Monohydrate 100mg Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Ranbaxy Laboratories Limited","startDate":"2005-06","conditions":"Healthy","enrollment":32},{"nctId":"NCT00652795","phase":"PHASE1","title":"Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions","status":"COMPLETED","sponsor":"Par Pharmaceutical, Inc.","startDate":"2004-07","conditions":"To Determine Bioequivalence Under Fasting Conditions","enrollment":36},{"nctId":"NCT00041977","phase":"PHASE3","title":"Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea","status":"COMPLETED","sponsor":"CollaGenex Pharmaceuticals","startDate":"2002-06","conditions":"Acne Rosacea","enrollment":150}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"DIARRHOEA"},{"count":2,"reaction":"DYSPEPSIA"},{"count":2,"reaction":"HYPERHIDROSIS"},{"count":2,"reaction":"LIVER FUNCTION TEST ABNORMAL"},{"count":2,"reaction":"NAUSEA"},{"count":2,"reaction":"OESOPHAGEAL ULCER"},{"count":2,"reaction":"OESOPHAGITIS"},{"count":2,"reaction":"PHOTOSENSITIVITY REACTION"},{"count":2,"reaction":"PRURITUS"},{"count":2,"reaction":"RASH"}],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Doxycycline","Erythrocyte sedimentation rate (ESR)","Complete blood count (CBC).","Lipid profile","Renal and liver function tests"],"phase":"marketed","status":"active","brandName":"Doxycycline Tablets","genericName":"Doxycycline Tablets","companyName":"Yaounde Central Hospital","companyId":"yaounde-central-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing peptide bond formation and bacterial growth. Used for Bacterial infections including respiratory tract infections, urinary tract infections, and skin infections, Malaria prophylaxis and treatment, Acne vulgaris.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}